Conmed (CNMD) Q2 Earnings and Revenues Top Estimates

Company Performance - Conmed reported quarterly earnings of $1.15 per share, exceeding the Zacks Consensus Estimate of $1.13 per share, and up from $0.98 per share a year ago, representing an earnings surprise of +1.77% [1] - The company posted revenues of $342.35 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.81%, compared to year-ago revenues of $332.1 million [2] - Over the last four quarters, Conmed has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance - Conmed shares have declined approximately 26.5% since the beginning of the year, while the S&P 500 has gained 8.3% [3] - The current Zacks Rank for Conmed is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.01 on revenues of $335.21 million, and for the current fiscal year, it is $4.42 on revenues of $1.37 billion [7] - The outlook for the Medical - Dental Supplies industry, where Conmed operates, is currently in the top 12% of over 250 Zacks industries, suggesting a favorable environment for performance [8]